RJA
VSTM icon

Raymond James & Associates’s Verastem VSTM Stock Holding History

Raymond James & Associates’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,725
Closed -$18.6K – 3981
2023
Q1 		$18.6K Sell
3,725
-104
-3% -$658 ﹤0.01% 3804
2022
Q4 		$18.5K Sell
3,829
-6,169
-62% -$30.3K ﹤0.01% 3801
2022
Q3 		$102K Sell
9,998
-132
-1% -$1.84K ﹤0.01% 3608
2022
Q2 		$141K Buy
10,130
+169
+2% +$2.69K ﹤0.01% 3606
2022
Q1 		$169K Sell
9,961
-16,155
-62% -$278K ﹤0.01% 3716
2021
Q4 		$642K Sell
26,116
-1,380
-5% -$43.6K ﹤0.01% 2907
2021
Q3 		$1.02M Buy
27,496
+23,342
+562% +$858K ﹤0.01% 2576
2021
Q2 		$203K Sell
4,154
-444
-10% -$18.5K ﹤0.01% 3679
2021
Q1 		$136K Buy
4,598
+92
+2% +$2.58K ﹤0.01% 3717
2020
Q4 		$115K Buy
4,506
+12
+0.3% +$241 ﹤0.01% 3536
2020
Q3 		$65K Sell
4,494
-24
-0.5% -$397 ﹤0.01% 3432
2020
Q2 		$93K Buy
4,518
+8
+0.2% +$212 ﹤0.01% 3299
2020
Q1 		$143K Sell
4,510
-845
-16% -$21.2K ﹤0.01% 3138
2019
Q4 		$86K Buy
5,355
+188
+4% +$2.7K ﹤0.01% 3492
2019
Q3 		$75K Buy
5,167
+11
+0.2% +$179 ﹤0.01% 3427
2019
Q2 		$93K Buy
5,156
+1,080
+26% +$24.5K ﹤0.01% 3419
2019
Q1 		$145K Buy
4,076
+542
+15% +$21.4K ﹤0.01% 3323
2018
Q4 		$142K Sell
3,534
-400
-10% -$24.4K ﹤0.01% 3235
2018
Q3 		$342K Buy
3,934
+1,610
+69% +$160K ﹤0.01% 2950
2018
Q2 		$192K Sell
2,324
-133
-5% -$8.14K ﹤0.01% 3274
2018
Q1 		$88K Sell
2,457
-2,234
-48% -$86.5K ﹤0.01% 3281
2017
Q4 		$173K Sell
4,691
-176
-4% -$7.95K ﹤0.01% 3106
2017
Q3 		$275K Buy
4,867
+3,813
+362% +$180K ﹤0.01% 2845
2017
Q2 		$28K Buy
+1,054
New +$26.8K ﹤0.01% 3231

Other funds holding VSTM

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Raymond James & Associates's VSTM Position: Q2 2023 in Review

Raymond James & Associates sold out of Verastem (VSTM) in Q2 2023, closing a stake of 3,725 shares — an estimated $18.6K sold.

Raymond James & Associates first reported a position in VSTM in Q2 2017 and held it in 24 quarters. The position peaked at $1.02M in Q3 2021. 61 funds tracked by Wall St. Rank hold VSTM as of Q2 2023.

  • Raymond James & Associates reported no remaining Verastem position as of Q2 2023 after selling out during the quarter.
  • Raymond James & Associates sold 3,725 Verastem shares in Q2 2023, an estimated $18.6K.
  • Raymond James & Associates first reported a position in Verastem in Q2 2017 and held it in 24 quarters.
  • Raymond James & Associates's Verastem position peaked at $1.02M in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Verastem as of Q2 2023.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.